Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Molecular Diagnostics For Sexually Transmitted Diseases Industry?
The market size for molecular diagnostics used for sexually transmitted diseases has experienced a speedy growth recently. It is predicted to rise from $3.31 billion in 2024 to $3.67 billion by 2025, suggesting a compound annual growth rate (CAGR) of 10.9%. Factors like increased instances of sexually transmitted infections, the rising application of nucleic acid amplification tests, growing cognizance through government instituted screening programs, assistance from worldwide health organizations, and swift adoption in diagnostic laboratories have contributed to the expansion observed in the historic period.
The demand for molecular diagnostics in the marketplace for sexually transmitted diseases is predicted to experience significant expansion in the coming years. The market size is projected to reach $5.48 billion by 2029, propelled by a compound annual growth rate (CAGR) of 10.5%. The projected surge during the forecast period can be linked to an emphasis on early detection of diseases, surging demand for individualized diagnostics, the growth of sexually transmitted infection monitoring programs, the proliferation of public-private partnerships, and an escalating preference for non-invasive testing methods. The forecast period will also witness technological advancements in the field of molecular assay platforms, point-of-care diagnostic device innovation, the evolution of multiplex polymerase chain reaction (PCR)-based testing panels, in-depth research and improvement of portable and automated systems, as well as the adoption of artificial intelligence in result interpretation.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27351&type=smp
What Forces Are Driving The Growth Of The Molecular Diagnostics For Sexually Transmitted Diseases Industry?
An upward trend in sexually transmitted infections (STIs) is anticipated to fuel the expansion of the molecular diagnostics market for sexually transmitted diseases. STIs, infections transmitted primarily through sexual activity, can be caused by bacteria, viruses, or parasites and can affect the urinary and reproductive systems. The rising incidence of STIs is largely attributed to inconsistent use of protective methods, elevating the risk of transmitting infections among sexually active people. The crucial role of molecular diagnostics in the management of STIs cannot be understated. It allows for earlier and more precise pathogen detection – even in asymptomatic individuals. This leads to punctual treatment, minimized transmission of the disease, and improved patient outcomes overall. For example, The National Association of County and City Health Officials (NACCHO), a US nonprofit organization, reported a total of 3,755 congenital syphilis cases in January 2024, marking a 31% increase between 2021 and 2022. Hence, the expanding prevalence of STIs is contributing to the growth of the molecular diagnostics market for sexually transmitted diseases.
What Is The Overview Of Market Segmentation In The Molecular Diagnostics For Sexually Transmitted Diseases Industry?
The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented
1) By Product: Instruments And Services, Consumables, Software
2) By Technology: Laboratory Testing, Point-Of-Care Testing
3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications
Subsegment:
1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services
2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers
3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software
What Future Market Trends Are Projected For The Molecular Diagnostics For Sexually Transmitted Diseases Industry?
Leading firms in the sexually transmitted diseases molecular diagnostics market are primarily concentrating on the creation of innovative solutions, including quick point-of-care polymerase chain reaction (PCR) devices, to augment diagnostic speed, precision, and approachability. Quick point-of-care polymerase chain reaction (PCR) devices are mobile molecular diagnostic instruments that integrates the preparation, amplification, and detection of a sample into a single, convenient unit, thereby enabling swift and highly sensitive pathogen identification beyond traditional laboratory environments. For instance, in March 2025, Visby Medical, a diagnostic technology firm based in the US, introduced the Visby Medical Women’s Sexual Health Test. This product is a single-use, portable PCR device built to detect chlamydia, gonorrhea, and trichomoniasis from vaginal samples in under 30 minutes. It functions without external instruments or cold-chain logistics, has a built-in amplification system, and provides lab-grade results right at the point of care to aid instant clinical decisions. The test has been authorized for prescription home use, making it the first molecular diagnostic test for multiple sexually transmitted infections (STIs) approved by the U.S. Food and Drug Administration (FDA) for use outside of clinical settings. This release signifies a transition towards decentralized diagnostic solutions that expand accessibility, majorly among underserved or distant populations.
Who Are The Primary Players Operating Across The Global Molecular Diagnostics For Sexually Transmitted Diseases Market?
Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, and Solone Life Sciences India (P) Ltd.
Get The Full Report Here:
Which Region Offers The Most Growth Potential For The Molecular Diagnostics For Sexually Transmitted Diseases Market Through 2029?
North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27351&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model